Confirming the results of our initial screen using littermate controls, we found a reduced number of metastases in the lungs of Arhgef1-deficient mice compared with wild-type controls after intravenous injection of syngeneic B16 melanoma cells (Fig. 1a,b). This evidence concerns the gene ARHGEF1 and melanoma.